HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
March 10, 2021 16:02 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 10, 2021 (GLOBE NEWSWIRE) -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is...
Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline
September 04, 2018 17:05 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Lead Plaintiff deadline in...
Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline
August 03, 2018 16:32 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Lead Plaintiff deadline in...
Hagens Berman Alerts Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) to the September 17, 2018 Securities Class Action Lead Plaintiff Deadline
July 20, 2018 16:59 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to the September 17, 2018 Lead Plaintiff deadline in...